The global anti-fungal drugs market size is likely to reach USD 13.17 billion by 2027 on account of the increasing prevalence of skin infections worldwide. Mycosis or fungal infection is a skin disease caused by a group of spore-producing organisms living and feeding on the human skin. When untreated, they lead to skin issues such as rashes, athlete’s foot, yeast infection, ringworm, nail fungus, bumps, and others. According to a recently published report by Fortune Business Insights™ titled, “Anti-Fungal Drugs Market Size, Share & Industry Analysis, By Drug Type (Echinocandins, Azoles, Polyenes, and Allylamines), By Indication (Dermatophytosis, Aspergillosis, Candidiasis, and Others), By Route of Administration (Oral, Topical, and Parenteral), By Distribution Channel (Hospital Pharmacies, Retails Pharmacies & Stores, and Others), and Regional Forecast, 2020-2027,” the market value was USD 10.24 billion in 2019, and will exhibit a CAGR of 3.3% between 2020 and 2027.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/antifungal-drugs-market-101188
Highlights of the Report:
- In-depth analysis of various insights, namely, Anti-Fungal Drugs Market trends, growth drivers, opportunities, and other related challenges.
- Comprehensive details of key market players, their core competencies, and Anti-Fungal Drugs Market share.
- The potency of suppliers and buyers to make better business decisions.
- Lists out the market size in terms of volume.
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this, too, shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. Some industries are struggling, and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are making continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.
Click here to get the short-term and long-term impact of COVID-19 on this Market.
Please visit: https://www.fortunebusinessinsights.com/industry-reports/antifungal-drugs-market-101188
Key Players Operating in The Anti-Fungal Drugs Market Include:
Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:
- Merck & Co., Inc.
- Leadiant Biosciences, Inc.
- GlaxoSmithKline plc.
- Bayer AG
- Astellas Pharma Inc.
- Pfizer Inc.
- McKesson Medical-Surgical Inc.
- Novartis AG
- Abbott
- Other Players
Geographical Segmentation
North America will Continue Dominating Owing to Availability of Better Healthcare Facilities
North America emerged dominant with a revenue of USD 4.61 billion earned in 2019. The growth of this region is attributed to a rise in the awareness about hygiene and the increasing adoption of advanced therapeutics for diagnostic purposes. This, coupled with the presence of better healthcare infrastructure and medical facilities are likely to aid in the expansion of the regional market in the coming years, thereby increasing the demand for anti-fungal drugs.
On the other side, Europe will rank second owing to the developing healthcare infrastructure and the increasing number of patients suffering from fungal infections. Furthermore, the market in Asia Pacific will emerge as the fastest-growing market on account of the rising research and development activities by major players, a surge in the number of hospital-oriented infections, and supportive government awareness programs about personal health and hygiene.
Detailed Table of Content:
- Introduction
- Research Scope
- Market Segmentation
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Key Insights
- Key Industry Developments (Mergers, Acquisitions, and Partnerships, etc.)
- Prevalence of Fungal Infections
- Pipeline Analysis
- New Product Launches
- Global Anti-Fungal Drugs Market Analysis, Insights and Forecast, 2016-2027
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Drug Type
- Azoles
- Echinocandins
- Polyenes
- Allylamines
- Market Analysis, Insights and Forecast – By Indication
- Dermatophytosis
- Candidiasis
- Aspergillosis
- Others
- Market Analysis, Insights and Forecast – By Route of Administration
- Oral
- Topical
- Parenteral
- Market Analysis, Insights and Forecast – By Distribution Channel
- Hospitals Pharmacies
- Retail Pharmacies & Drug Stores
- Online Pharmacies
- Market Analysis, Insights and Forecast – By Region
- North America
- Europe
- Asia pacific
- Latin America
- Middle East & Africa
- North America Anti-Fungal Drugs Market Analysis, Insights and Forecast, 2016-2027
- Key Findings / Summary
- Market Analysis – By Drug Type
- Azoles
- Echinocandins
- Polyenes
- Allylamines
- Market Analysis – By Indication
- Dermatophytosis
- Candidiasis
- Aspergillosis
- Others
- Market Analysis – By Route of Administration
- Oral
- Topical
- Parenteral
- Market Analysis – By Distribution Channel
- Hospitals Pharmacies
- Retail Pharmacies & Drug Stores
- Online Pharmacies
- Market Analysis – By Country
- S.
- Canada
- Europe Anti-Fungal Drugs Market Analysis, Insights and Forecast, 2016-2027
- Key Findings / Summary
- Market Analysis – By Drug Type
- Azoles
- Echinocandins
- Polyenes
- Allylamines
- Market Analysis – By Indication
- Dermatophytosis
- Candidiasis
- Aspergillosis
- Others
- Market Analysis – By Route of Administration
- Oral
- Topical
- Parenteral
- Market Analysis – By Distribution Channel
- Hospitals Pharmacies
- Retail Pharmacies & Drug Stores
- Online Pharmacies
- Market Analysis – By Country/ sub-region
- K.
- Germany
- France
- Spain
- Italy
- Scandinavia
- Rest of Europe
- Asia pacific Anti-Fungal Drugs Market Analysis, Insights and Forecast, 2016-2027
- Key Findings / Summary
- Market Analysis – By Drug Type
- Azoles
- Echinocandins
- Polyenes
- Allylamines
- Market Analysis – By Indication
- Dermatophytosis
- Candidiasis
- Aspergillosis
- Others
- Market Analysis – By Route of Administration
- Oral
- Topical
- Parenteral
- Market Analysis – By Distribution Channel
- Hospitals Pharmacies
- Retail Pharmacies & Drug Stores
- Online Pharmacies
- Market Analysis – By Country/ sub-region
- Japan
- China
- India
- Australia
- Southeast Asia
- Rest of Asia Pacific
- Latin America Anti-Fungal Drugs Market Analysis, Insights and Forecast, 2016-2027
- Key Findings / Summary
- Market Analysis – By Drug Type
- Azoles
- Echinocandins
- Polyenes
- Allylamines
- Market Analysis – By Indication
- Dermatophytosis
- Candidiasis
- Aspergillosis
- Others
- Market Analysis – By Route of Administration
- Oral
- Topical
- Parenteral
- Market Analysis – By Distribution Channel
- Hospitals Pharmacies
- Retail Pharmacies & Drug Stores
- Online Pharmacies
- Market Analysis – By Country/ sub-region
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa Anti-Fungal Drugs Market Analysis, Insights and Forecast, 2016-2027
- Key Findings / Summary
- Market Analysis – By Drug Type
- Azoles
- Echinocandins
- Polyenes
- Allylamines
- Market Analysis – By Indication
- Dermatophytosis
- Candidiasis
- Aspergillosis
- Others
- Market Analysis – By Route of Administration
- Oral
- Topical
- Parenteral
- Market Analysis – By Distribution Channel
- Hospitals Pharmacies
- Retail Pharmacies & Drug Stores
- Online Pharmacies
- Market Analysis – By Country/ sub-region
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Continued…
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/antifungal-drugs-market-101188
Report Focus:
- Extensive product offerings
- Customer research services
- Robust research methodology
- Comprehensive reports
- Latest technological developments
- Value chain analysis
- Potential Anti-Fungal Drugs Market opportunities
- Growth dynamics
- Quality assurance
- Post-sales support
- Regular report updates
Reasons to Purchase this Report:
- Comprehensive analysis of the Anti-Fungal Drugs Market growth drivers, obstacles, opportunities, and other related challenges.
- Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.
- Identifies market restraints and boosters.
- Identifies all the possible segments present in the market to aid organizations in strategic business planning.
KEY QUESTIONS ANSWERED:
- What is the market size and growth rate of the global and regional market by various segments?
- What is the market size and growth rate of the market for selective countries?
- Which region or sub-segment is expected to drive the market in the forecast period?
- What Factors are estimated to drive and restrain the Anti-Fungal Drugs Market growth?
- What are the key technological and market trends shaping the market?
- What are the key opportunities in the market?
- What are the key companies operating in the market?
- Which company accounted for the highest market share?
More Trending Topics From Fortune Business Insights@
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245